CA2660962A1 - Nouvelle composition pharmaceutique pour le traitement de la schizophrenie - Google Patents

Nouvelle composition pharmaceutique pour le traitement de la schizophrenie Download PDF

Info

Publication number
CA2660962A1
CA2660962A1 CA2660962A CA2660962A CA2660962A1 CA 2660962 A1 CA2660962 A1 CA 2660962A1 CA 2660962 A CA2660962 A CA 2660962A CA 2660962 A CA2660962 A CA 2660962A CA 2660962 A1 CA2660962 A1 CA 2660962A1
Authority
CA
Canada
Prior art keywords
lower alkyl
substituted
schizophrenia
pharmaceutical composition
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2660962A
Other languages
English (en)
Inventor
Shinji Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Priority to CA2660962A priority Critical patent/CA2660962A1/fr
Priority to KR1020117025603A priority patent/KR20120004488A/ko
Priority to EP10719652A priority patent/EP2413940A1/fr
Priority to JP2011541012A priority patent/JP2012521963A/ja
Priority to PCT/JP2010/056144 priority patent/WO2010114163A1/fr
Priority to CN2010800150329A priority patent/CN102378630A/zh
Priority to TW099109850A priority patent/TW201035081A/zh
Publication of CA2660962A1 publication Critical patent/CA2660962A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CA2660962A 2009-03-31 2009-03-31 Nouvelle composition pharmaceutique pour le traitement de la schizophrenie Abandoned CA2660962A1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
CA2660962A CA2660962A1 (fr) 2009-03-31 2009-03-31 Nouvelle composition pharmaceutique pour le traitement de la schizophrenie
KR1020117025603A KR20120004488A (ko) 2009-03-31 2010-03-30 정신분열증의 치료를 위한 2,4,6-트리아미노-1,3,5-트리아진 유도체를 포함하는 조성물
EP10719652A EP2413940A1 (fr) 2009-03-31 2010-03-30 Compositions comprenant des derives de 2, 4, 6-triamino-1, 3, 5-triazine pour le traitement de la schizophrenie
JP2011541012A JP2012521963A (ja) 2009-03-31 2010-03-30 新規統合失調症治療用医薬組成物
PCT/JP2010/056144 WO2010114163A1 (fr) 2009-03-31 2010-03-30 Compositions comprenant des derives de 2, 4, 6-triamino-1, 3, 5-triazine pour le traitement de la schizophrenie
CN2010800150329A CN102378630A (zh) 2009-03-31 2010-03-30 用于治疗精神***症的包含2,4,6-三氨基-1,3,5-三嗪衍生物的组合物
TW099109850A TW201035081A (en) 2009-03-31 2010-03-31 Novel pharmaceutical composition for treatment of schizophrenia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2660962A CA2660962A1 (fr) 2009-03-31 2009-03-31 Nouvelle composition pharmaceutique pour le traitement de la schizophrenie

Publications (1)

Publication Number Publication Date
CA2660962A1 true CA2660962A1 (fr) 2010-09-30

Family

ID=42269730

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2660962A Abandoned CA2660962A1 (fr) 2009-03-31 2009-03-31 Nouvelle composition pharmaceutique pour le traitement de la schizophrenie

Country Status (7)

Country Link
EP (1) EP2413940A1 (fr)
JP (1) JP2012521963A (fr)
KR (1) KR20120004488A (fr)
CN (1) CN102378630A (fr)
CA (1) CA2660962A1 (fr)
TW (1) TW201035081A (fr)
WO (1) WO2010114163A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103351348A (zh) * 2013-07-15 2013-10-16 黄河三角洲京博化工研究院有限公司 一种2-甲胺基嘧啶盐酸盐的合成方法
KR200492485Y1 (ko) 2016-02-16 2020-10-23 주식회사 마르시끄 일회용 마스카라

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1982799A (en) 1998-01-23 1999-08-09 Yamanouchi Pharmaceutical Co., Ltd. Novel potassium channel protein
BR0116411A (pt) 2000-12-21 2003-11-11 Vertex Pharma Compostos de pirazol úteis como inibidores de proteìna cinase
KR100875362B1 (ko) * 2002-02-05 2008-12-22 아스텔라스세이야쿠 가부시키가이샤 2,4,6-트리아미노-1,3,5-트리아진 유도체
EP2134744A2 (fr) * 2007-03-26 2009-12-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Isoforme du kcnh2 associé à la schizophrénie et développement de médicaments antipsychotiques

Also Published As

Publication number Publication date
EP2413940A1 (fr) 2012-02-08
TW201035081A (en) 2010-10-01
KR20120004488A (ko) 2012-01-12
WO2010114163A1 (fr) 2010-10-07
JP2012521963A (ja) 2012-09-20
CN102378630A (zh) 2012-03-14

Similar Documents

Publication Publication Date Title
EP3564217B1 (fr) Antagoniste des récepteurs p2x4
EP1921077B1 (fr) Agent de traitement et/ou de prevention des troubles du sommeil
CA3112129A1 (fr) Polytherapies
CN104302295B (zh) 用tor 激酶抑制剂治疗癌症
JP2007529491A (ja) ベンゾジアゼピン誘導体およびｒｓｖ融合タンパク質阻害剤を含む医薬組成物
TW200413374A (en) Novel adenine derivative and its use
EP3077391B1 (fr) Utilisation de dérivés de benzimidazole-proline
EP3570940B1 (fr) Pridopidine pour utilisation pour traiter le syndrome de l'x fragile
CN111788182B (zh) 毒蕈碱性乙酰胆碱受体m4的拮抗剂
EP2796450B1 (fr) Dérivés 6-aminopyridine-3-ol ou leurs sels pharmaceutiquement acceptables, et composition pharmaceutique contenant ces dérivés ou ces sels comme principes actifs pour la prévention ou le traitement des maladies provoquées par l'angiogenèse
AU2013350819B9 (en) Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia
US9540332B2 (en) Benzimidazole derivatives as selective blockers of persistent sodium current
CA2660962A1 (fr) Nouvelle composition pharmaceutique pour le traitement de la schizophrenie
US20100256152A1 (en) Novel pharmaceutical composition for treatment of schizophrenia
CN107438435A (zh) 抗‑hcmv组合物和方法
US20130172342A1 (en) Benzimidazole derivatives as selective blockers of persistent sodium current
EP4324833A1 (fr) Composé d'alkynylphénylbenzamide et son utilisation
US20120088772A1 (en) Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
CN113754580B (zh) 一种吡啶吗啉类化合物、其制备方法及其应用
AU2009201338A1 (en) Novel pharmaceutical composition for treatment of schizophrenia
BRPI0901286A2 (pt) nova composição farmacêutica para o tratamento da esquizofrenia
CA3101143A1 (fr) Forme de sel
CN112912078B (zh) 用于治疗***受体阳性乳腺癌的组合疗法
CA2660954A1 (fr) Nouveau sel de derive de 1,3,5-triazine-2,4,6-triamine
CN117285484A (zh) 抑制hdac6酶的苯并噻二嗪1,1-二氧化物类化合物及其制备方法和应用

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20150331